1. Boyd, M. R., and L. T. Buka. 1978. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J. Pharmacol. Exp. Ther. 207:687–697.
2. Coon, M. J., A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, and P. J. O’Brien, eds. 1980. Microsomes, Drug Oxidations, and Chemical Carcinogenesis ,Volumes I and II. Academic Press, New York. 1258 pp.
3. De Matteis, F., and L. Cantoni. 1970. Alteration of the porphyrin nucleus of cytochrome P-450 caused in the liver by treatment with allyl-containing drugs. Is the modified porphyrin N-substituted? Biochem. J. 183:99–103.
4. Doull, J., C. D. Klaassen, and M. O. Amdur, eds. 1980. Toxicology, The Basic Science of Poisons ,2nd ed. Macmillan, New York.
5. Ehrenberg, L., S. Osterman-Golkar, D. Segerback, K. Svensson, and C. J. Calleman. 1977. Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethylene oxide in vivo. Mutat. Res. 45:175–184.